Citius Oncology CTOR
NASDAQ CTOR
$0.70 +0.03 (+4.32%)
As of: Oct 21, 2026 · 11:19 AM EDT

Citius Oncology (CTOR) Interest Paid (2025 - 2026)

Updated

Analysis

Citius Oncology (CTOR) Interest Paid (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn -
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn -
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn -
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 1.07 Bn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn -
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 1.25 Bn
10 Citius Oncology 75.52 Mn 45.11 Mn 1.00 Mn 198,334.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198,334.00
Dec 31, 2025 14,460.00
API Access

Citius Oncology Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=CTOR&period=max&api_key=YOUR_API_KEY